A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway

<div>Measurement of antioxidant activity of the complex. Antioxidant activity of the ruthenium-fluvastatin complex by the (a) ABTS method, (b) DPPH method, and (c) FRAP method. (d) Absorbance spectra of CT-DNA in the presence of the ruthenium-fluvastatin complex.</div>

Oxidative Medicine and Cellular Longevity

fig5

Figure 5

Figure 5: A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway 

Figure 5 | A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway 